Statistically significantly more patients were treatment successes with SPHAL ( upper lip [ 80.2 % vs 11.9 % ] , lower lip [ 84.2 % vs 18.4 % ] , and upper and lower lips combined [ 76.1 % vs 11.6 % ] ) , compared with no treatment ( p < .001 , all outcomes ) .